Leveraging Evolving Data to Inform Treatment in HR-Positive, HER2-Negative Advanced Breast Cancer

Watch the interactive on-demand Webcast and download the slides from a CCO symposium at SABCS 2019 to get up to date on the latest clinical data informing optimal treatment of HR+/HER2- MBC including expert discussion of patient cases and  a look ahead at promising agents in the setting of endocrine therapy&ndash pretreated disease that may soon change practice.

Share

Program Content

No activities added yet

Activities

Future Directions in HR+/HER2- MBC
Novel Therapeutics for HR+/HER2- Metastatic Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2019

Expires: December 09, 2020

PI3K Blockade in HR+/HER2- MBC
Beyond CDK4/6 Inhibition: Putting New Data on Targeting the PI3K Pathway Into Clinical Practice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2019

Expires: December 09, 2020

CDK4/6i for HR+/HER2- MBC
CDK4/6 Inhibitors in the Management of HR+/HER2- MBC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2019

Expires: December 09, 2020

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Immunomedics

Lilly